News and Features Related to Parkinson's Disease
-
FDA Approves 1st Parkinson's Patch
May 9, 2007 -- The FDA today announced the approval of Neupro, the first skin patch designed to treat symptoms of early Parkinson's disease. In a healthy brain, certain brain cells produce a chemical called dopamine, which helps the brain coordinate the body's movements. In Parkinson's disease, dopa
Read Full Article -
Depression Before Parkinson's Disease?
April 27, 2007 -- Depression may sometimes precede Parkinson's disease, a new study shows. The researchers -- who included Miguel Hernan, MD, DrPH, of the Harvard School of Public Health -- used a medical database of more than 3 million people in the U.K. The researchers compared data on 1,052 Parki
Read Full Article -
Exercise May Help Prevent Parkinson's
April 23, 2007 -- People who exercise regularly may be less likely to develop Parkinson's disease -- but leisurely strolls may not be enough. That news comes from a study of more than 143,300 U.S. men and women who were followed from 1992-2001. When the study started, participants were 63 years old,
Read Full Article -
Senate Passes New Stem Cell Bill
April 11, 2007 -- The Senate voted Wednesday to repeal the Bush administration's restrictions on embryonic stem cell research, marking the second time in less than a year Congress has voted by wide bipartisan margins to reverse the president. President Bush vetoed the bill last year and threatened T
Read Full Article -
Study: Less Parkinson's in Smokers
April 9, 2007 -- A study of families with Parkinson's disease shows that smoking and caffeine use protect against the deadly brain disorder. Previous studies suggested that people with Parkinson's disease are more likely than other people to be smokers and coffee drinkers. To see if this is true, Da
Read Full Article -
24-Hour Parkinson’s Drug Cuts Symptoms
April 4, 2007 -- A new 24-hour form of the Parkinson’s drug Requip may provide longer-lasting relief from symptoms and reduce the need for other drugs to control the disease. A new study shows the longer-acting version of Requip reduced by more than two hours the daily “off time” Parkinson’s patient
Read Full Article -
Parkinson's Drug Taken Off Market
March 29, 2007 -- The FDA today announced that the Parkinson's disease drug Permax and its generic versions (pergolide) are being voluntarily taken off the U.S. market because of the risk of serious damage to the heart's valves. Pergolide, approved by the FDA in 1988, already carried a "black box" w
Read Full Article -
Epilepsy Drug May Treat Parkinson's
Jan. 4, 2007 -- The epilepsy drug zonisamide may help curb the tremors and other movement problems of Parkinson's, a Japanese study shows. Zonisamide is sold in the U.S. generically and under the brand name Zonegran. In Parkinson's disease , the brain cells that make dopamine, a chemical that helps
Read Full Article -
Parkinson's Patch Nears U.S. Approval
Jan. 3, 2007 -- A once-a-day patch is a safe and effective treatment for early Parkinson's disease , a clinical trial shows. Transdermal rotigotine is the patch's scientific name. Under the brand name Neupro, it's already sold in Europe by manufacturer Schwarz Pharma. Study leader Ray L. Watts, MD,
Read Full Article -
Parkinson's Drugs: Heart Damage Link?
Jan. 3, 2007 -- Two drugs used in the treatment of Parkinson's disease appear to increase the risk of heart valve disease, according to new research that also raises safety questions about similar-acting drugs. The drugs pergolide, marketed as Permax, and cabergoline, sold as Dostinex, were associat
Read Full Article
Related to Parkinson's Disease
Today in Parkinson’s Disease
Health Solutions From Our Sponsors
©2005-2013 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.